Table 3.
Regulation of Genes that were not Differentially Following IGF-1 Treatment.
Gene | Regulation | Reference | Expression depends upon |
BRCA-1 | Cre | [55] | Methylation |
Catalase | CCAAT, ERG-1, SP-1, NF-Y | [56] | Acetylation? |
Estrogen receptor-alpha | AP-2, CpG islands, | [57–59] | Methylation |
Glutathione S-transferase pi | AP-1, SP-1, CpG islands | [60–62] | Methylation |
Gycogen synthase kinase-alpha | AP-1, YY-1, LSF, MZF-1, SP-1, CRE | [63] | Unknown |
Multidrug resistance-1 | AP-1, YB-1, CCAAT | [64,65] | Methylation |
Topoisomerase II | CCAAT, Acetylation | [66] | Acetylation |
Topoisomerase III | SP-1 (4), YY-1, USF-1 | [67] | Methylation |
In silico promoter analysis of genes that were printed on the microarray chip but not induced by IGF-1. Eight genes were randomly selected from our gene list and their promoters were queried for transcription factor-binding sites. Although many of the promoters had common transcription factor-binding sites such as CRE and AP-1, their expression depended upon methylation.